Table 3.

Demographic and clinical factors associated with health-related work cessation* risk among Carolina Lupus Study patients, 2001 followup.

nUnadjustedAdjusted
OR(95% CI)OR95% CI
Age1980.98(0.96, 1.01)0.98(0.95, 1.00)
Male190.35(0.08, 1.6)0.36(0.07, 1.8)
Female1791.0(referent)1.0(referent)
African Americans and other minorities1261.9(0.93, 4.0)1.6(0.71, 3.5)
White721.0(referent)1.0(referent)
College graduate
  Yes470.31(0.11, 0.83)0.27(0.09, 0.84)
  No1511.0(referent)1.0(referent)
State
  North Carolina1570.96(0.43, 2.1)1.0(0.41, 2.4)
  South Carolina411.0(referent)1.0(referent)
Practice type
  University971.8(0.91, 3.5)1.7(0.76, 3.6)
  Community1011.0(referent)1.0(referent)
Arthritis
  Present1432.8(1.1, 7.1)3.3(1.2, 8.8)
  Absent511.0(referent)1.0(referent)
Pleuritis
  Present762.1(1.1, 4.1)2.3(1.1, 4.6)
  Absent1161.0(referent)1.0(referent)
Thrombocytopenia
  Present221.6(0.62, 4.3)2.1(0.69, 6.3)
  Absent1711.0(referent)1.0(referent)
Lupus nephritis
  Present471.2(0.55, 2.5)0.85(0.34, 2.1)
  Absent1471.0(referent)1.0(referent)
Anti-dsDNA antibodies
  Present501.1(0.50, 2.3)0.73(0.30, 1.7)
  Absent1371.0(referent)1.0(referent)
  • * Work loss defined as stopping work, between year before diagnosis and followup interview, because of health (n = 47).

  • Adjusted for age, gender, ethnicity, education (college graduate vs non-college graduate), arthritis, and pleuritis.